Hostname: page-component-788cddb947-jbkpb Total loading time: 0 Render date: 2024-10-12T01:29:37.125Z Has data issue: false hasContentIssue false

Low dietary calcium in European postmenopausal osteoporotic women

Published online by Cambridge University Press:  01 January 2009

Olivier Bruyere*
Affiliation:
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Caroline De Cock
Affiliation:
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Catherine Mottet
Affiliation:
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Audrey Neuprez
Affiliation:
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Olivier Malaise
Affiliation:
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
Jean-Yves Reginster
Affiliation:
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders and Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium
*
*Corresponding author: Email olivier.bruyere@ulg.ac.be
Rights & Permissions [Opens in a new window]

Abstract

Objective

The WHO recommends a daily Ca intake for postmenopausal women of 1300 mg. The objective of the present study was to assess the dietary Ca intake in European postmenopausal osteoporotic women.

Design, setting and subjects

Assessment of dietary Ca intake (food and supplements) was performed with a validated self-questionnaire in 8524 osteoporotic women from nine European countries (Belgium, Denmark, France, Germany, Hungary, Italy, Poland, Spain and the UK).

Results

Mean age of the patients was 74·2 (sd 7·1) years, mean BMI was 25·7 (sd 4·2) kg/m2. Of the study population, 37·2 % of the women took Ca supplements. The mean dietary intake of Ca was 930·7 (sd 422·9) mg/d. The lowest Ca intake was found in Hungary (586·7 (sd 319·1) mg/d) and the highest in Denmark (1145·6 (sd 463·0) mg/d). In the whole study population, only 19·1 % of the women had a dietary Ca intake >1300 mg/d. Only 17·1 % of women aged over 75 years achieved 1300 mg/d compared with 20·5 % of women aged less than 75 years (P = 0·0001 for the difference between the two groups).

Conclusion

Dietary intake of Ca is very low in European postmenopausal women. A greater awareness is needed to resolve this public health problem.

Type
Research Paper
Copyright
Copyright © The Authors 2008

Osteoporosis is characterized by increased skeletal fragility and susceptibility to fractures, leading to a significant increase in morbidity and mortality(Reference Gallagher, Fowler, Detter and Sherman1). Because of the ageing of the European population, a preventive strategy for osteoporosis has become a public health priority.

Ca is an essential nutrient that plays a vital role in neuromuscular function, many enzyme-mediated processes, blood clotting, and provides rigidity to the skeleton by virtue of its phosphate salts(2). Ca consumption also influences the maintenance of bone mass(Reference Heaney3). Nearly all (i.e. 99 %) of total body Ca is located in the skeleton and the remaining 1 % is equally distributed between the teeth and soft tissues, with only 0·1 % in the extracellular compartment(2, Reference Robertson and Marshall4).

The Ca needs for adults are generally recognized as the intake required to maintain Ca balance and, therefore, skeletal integrity(2, Reference Ilich, Brownbill and Tamborini5). The Recommended Dietary Allowance (RDA) for European adults is 800 mg/d(Reference Hautvast, Baya and Amorim Cruz6). After menopause, Ca requirements increase to at least 1000 mg/d(Reference Heaney, Recker and Saville7, 8). The WHO recommendation for European postmenopausal women is 1300 mg/d(2, Reference Heaney3).

The objective of the present study was to assess the daily dietary Ca intake in European postmenopausal osteoporotic women.

Methods

Postmenopausal women aged over 50 years were included in the study. These women were part of a run-in study aimed at normalizing the Ca and vitamin D status of osteoporotic patients prior to their inclusion in a trial investigating the anti-fracture efficacy of a new anti-osteoporotic drug. Patients were considered osteoporotic if their lumbar spine or femoral neck bone mineral density was at least 2·5 standard deviations below the median T-score.

The present study involved 8524 patients from nine European countries: Belgium (n 1193), Denmark (n 327), France (n 1290), Germany (n 373), Hungary (n 353), Italy (n 1233), Poland (n 1544), Spain (n 590) and the UK (n 1621).

Assessment of Ca intake was performed with a previously validated self-questionnaire(Reference Fardellone, Sebert, Bouraya, Bonidan, Leclercq, Doutrellot, Bellony and Dubreuil9). This questionnaire enables evaluation of the Ca content of the diet of an individual on the basis of twenty different types of food (items) rich in Ca and/or frequently eaten. Obviously, tablets of Ca taken as supplements were also considered. Our study population was divided into three categories of Ca consumption: <800 mg/d, 800–1300 mg/d and >1300 mg/d. These thresholds were fixed according to the RDA for European adults (800 mg/d)(Reference Hautvast, Baya and Amorim Cruz6) and the WHO recommendation for European postmenopausal women (1300 mg/d)(2).

Results

The mean age of the 8524 women included in the present study was 74·2 (sd 7·1) years, mean BMI was 25·7 (sd 4·2) kg/m2. Table 1 shows the characteristics of the patients according to category of dietary Ca intake (i.e. <800 mg/d, 800–1300 mg/d, >1300 mg/d).

Table 1 Baseline characteristics of women according to category of dietary calcium intake: European postmenopausal osteoporotic women

BMD, bone mineral density.

In the whole study population, 37·2 % of the women took Ca supplements (34·9 % of women aged over 75 years and 38·9 % of women aged less than 75 years). Mean daily food intake was significantly lower (P < 0.001) in subjects who did not take a Ca supplement.

The mean dietary Ca intake (food plus supplements) was 930·7 (sd 422·9) mg/d. Only 19·1 % of women (n 1628) had daily dietary Ca consumption >1300 mg. Moreover, 39·4 % (n 3360) of the study population had daily Ca dietary intake of 800–1300 mg and 41·5 % (n 3536) had an intake of <800 mg daily (Fig. 1).

Fig. 1 Proportion of women in the global population, women aged less than 75 years and women more than 75 years of age meeting different thresholds (░, <800 mg/d; □, 800–1300 mg/d; ▒, >1300 mg/d) of dietary calcium intake: European postmenopausal osteoporotic women

Daily Ca intake from food and supplements, stratified by country, is shown in Table 2. The highest level of daily Ca intake from food was found in Denmark (1145·6 mg/d) and the smallest in Hungary (586·7 mg/d). Figure 2 shows the proportions of women in the different countries according to intake category (i.e. <800 mg/d, 800–1300 mg/d, >1300 mg/d).

Table 2 Dietary calcium intake and the percentage of women taking calcium supplements in different countries: European postmenopausal osteoporotic women

Fig. 2 Proportion of women in different European countries meeting different thresholds (░, <800 mg/d; □, 800–1300 mg/d; ▒, >1300 mg/d) of dietary calcium intake: European postmenopausal osteoporotic women

We found the lowest dietary Ca inadequacy in women aged over 75 years compared with women aged less than 75 years (P < 0·0001). Only 17·1 % of women aged over 75 years achieved 1300 mg/d compared with 20·5 % of women aged less than 75 years (P = 0·0001 for the difference between the two groups) (Fig. 1).

Discussion

We have shown that the mean dietary Ca intake of European postmenopausal osteoporotic women was below the WHO recommendation. The majority of these women (41·5 %) took less Ca than that recommended for adults before menopause (800 mg/d) and only 19·1 % of them achieved the WHO recommendation (1300 mg/d) for this population. The level of daily Ca intake from food varied across different European countries but always remained below the WHO-recommended intake.

Other epidemiological studies have described low dietary Ca intake. In 131 healthy postmenopausal women aged 64·7 (sd 7·6) years, Andon et al. found mean Ca consumption of 606 (sd 302) mg/d(Reference Andon, Smith, Bracker, Sartoris, Saltman and Strause10). In late (≥5 years) postmenopausal women, Jensen et al.(Reference Jensen, Holloway, Block, Spiller, Gildengorin, Gunderson, Butterfield and Marcus11) described mean Ca consumption of 793 (sd 280) mg/d in women aged 65 years and older. In 184 elderly women aged over 65 years, Pfister et al.(Reference Pfister, Wul and Saville12) found a mean dietary Ca intake of 563.4 mg/d. The combined dietary Ca intake and supplement Ca intake in elderly women (>60 years old) participating in NHANES III (Third National Health and Nutrition Examination Survey) was 864 (sd 16) mg/d(Reference Ervin and Kennedy-Stephenson13). In a recent study, the mean dietary Ca intake reported by 167 postmenopausal women aged 40–65 years was 924 (sd 347) mg/d(Reference Cussler, Going, Houtkooper, Stanford, Blew, Flint-Wagner, Metcalfe, Choi and Lohman14).

Subjects included in the present study were women being screened for taking part in a study assessing the anti-fracture efficacy of a new anti-osteoporotic drug in postmenopausal osteoporosis. Other studies performed in such populations (i.e. screening for randomized controlled trials of anti-osteoporotic drugs) also described low Ca intake in postmenopausal osteoporotic women(Reference Liberman, Weiss, Broll, Minne, Quan, Bell, Rodriguez-Portales, Downs, Dequeker and Favus15Reference Reid, Ames, Evans, Gamble and Sharpe20). For example, in 1637 postmenopausal women with prior vertebral fractures, mean daily intake of Ca from food ranged from 675 mg to 786 mg in the different randomized groups(Reference Neer, Arnaud and Zanchetta19). In the baseline characterization of the Fracture Intervention Trial(Reference Black, Cummings and Karpf16), the mean Ca intake was 619 mg/d for the placebo group (n 1005) and 652 mg/d for the treatment group (n 1022).

In the present study, we have shown that the daily intake of Ca from food was low and that only 37·2 % of the women took Ca supplements. Foods provide the best way to meet the Ca requirement because they constitute good sources of other essential nutrients(Reference Heaney3). However, dietary Ca intake has been found to be dependent on socio-economic status(Reference Winzenberg, Riley, Frendin, Oldenburg and Jones21) and personal attitudes towards food (i.e. milk)(Reference Pfister, Wul and Saville12). Moreover, it is difficult to achieve vitamin and mineral requirements when daily energy intake is below 6·28 MJ (1500 kcal)(Reference Schlienger, Pradignac and Grunenberger22Reference Walker and Ball24). Thus different expert groups have recommended use of Ca supplements by postmenopausal osteoporotic women(Reference Boonen, Rizzoli, Meunier, Stone, Nuki, Syversen, Lehtonen-Veromaa, Lips, Johnell and Reginster25Reference Compston27). In the present study, it appeared that women who took Ca supplements had higher mean daily Ca intake from food (P < 0.001) compared with women who did not take supplements, probably because of a greater awareness of their osteoporosis disease.

Osteoporotic fractures occur predominantly in populations aged over 65 years(Reference Dhesi, Allain, Mangoni and Jackson28). Elderly populations have lower daily intakes of vitamins and minerals compared with younger populations(Reference Mowe and Bohmer29), partly because of a lower food intake. In the present study, we found the highest dietary Ca inadequacy in women aged less than 75 years compared with women aged over 75 years. Only 17·1 % of women aged over 75 years achieved 1300 mg Ca/d compared with 20·5 % of women aged less than 75 years. We used the WHO recommendation for postmenopausal women to set up a threshold of 1300 mg/d, but the National Institutes of Health consensus group recommends a Ca consumption of at least 1500 mg/d after 65 years(8, Reference Lowenstein30). Our results confirm the difficulty in achieving correct daily Ca intake by food consumption alone in old postmenopausal women. Unfortunately, it should be pointed out that only 36·8 % of these women used Ca supplements.

In the present study we assessed dietary Ca intake of a population screened prior to inclusion in a trial investigating the anti-fracture efficacy of an anti-osteoporotic drug. Because of the patient inclusion/exclusion criteria in this particular study, our population cannot be representative of the general population but more of an osteoporotic population starting a treatment.

Another limitation of the study relates to the Ca intake assessment, which was performed with a validated self-questionnaire(Reference Fardellone, Sebert, Bouraya, Bonidan, Leclercq, Doutrellot, Bellony and Dubreuil9). However, it should be pointed that some studies have found that some dietary recalls and records could have an underestimation of 25–30 %. However, even if our data are underestimated, our conclusion that dietary Ca intake is very low in European postmenopausal women is still true and could even be more serious.

Osteoporosis and its consequences are a serious public health problem in the ageing population(Reference Gallagher, Fowler, Detter and Sherman1, Reference Boonen, Bischoff-Ferrari, Cooper, Lips, Ljunggren, Meunier and Reginster31). Our study shows insufficient dietary Ca intakes in postmenopausal osteoporotic women (whatever the age) in nine European countries. A substantial part of our study population does not achieve the general recommendation for Ca intake in such a population. We believe that greater awareness of this public health problem could help the fight against osteoporosis.

Acknowledgements

Declaration of interest: The authors declare that they have no competing interest. No industry funding was received for the study. The authors thank Servier for providing access to their database.

Author contributions: design of the study – O.B. and J.-Y.R.; analysis of the results – O.B., C.D.C., C.M., A.N. and O.M.; interpretation of the results – O.B., C.D.C., C.M. and J.-Y.R.; draft of the manuscript – O.B. and C.D.C.; final approval of the manuscript – all authors.

References

1.Gallagher, JC, Fowler, SE, Detter, JR & Sherman, SS (2001) Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86, 36183628.CrossRefGoogle ScholarPubMed
2. Food and Agriculture Organization of the United Nations/World Health Organization (2002) Human vitamin and mineral requirements. http://www.fao.org/docrep/004/Y2809E/y2809e0h.htm#bm17.6(accessed October 2006).Google Scholar
3.Heaney, RP (2001) Calcium needs of the elderly to reduce fracture risk. J Am Coll Nutr 20, Suppl., 192S197S.CrossRefGoogle ScholarPubMed
4.Robertson, WG & Marshall, RW (1981) Ionized calcium in body fluids. Crit Rev Clin Lab Sci 15, 85125.CrossRefGoogle ScholarPubMed
5.Ilich, JZ, Brownbill, RA & Tamborini, L (2003) Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 57, 554565.CrossRefGoogle ScholarPubMed
6.Hautvast, JG, Baya, C, Amorim Cruz, JA et al. (1989) Recommended dietary allowances for Europe. Lancet 2, 1220.CrossRefGoogle ScholarPubMed
7.Heaney, RP, Recker, RR & Saville, PD (1978) Menopausal changes in calcium balance performance. J Lab Clin Med 92, 953963.Google ScholarPubMed
8.NIH Consensus conference (1994) Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 272, 19421948.Google Scholar
9.Fardellone, P, Sebert, JL, Bouraya, M, Bonidan, O, Leclercq, G, Doutrellot, C, Bellony, R & Dubreuil, A (1991) [Evaluation of the calcium content of diet by frequential self-questionnaire]. Rev Rhum Mal Osteoartic 58, 99103.Google ScholarPubMed
10.Andon, MB, Smith, KT, Bracker, M, Sartoris, D, Saltman, P & Strause, L (1991) Spinal bone density and calcium intake in healthy postmenopausal women. Am J Clin Nutr 54, 927929.CrossRefGoogle ScholarPubMed
11.Jensen, C, Holloway, L, Block, G, Spiller, G, Gildengorin, G, Gunderson, E, Butterfield, G & Marcus, R (2002) Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr 75, 11141120.CrossRefGoogle ScholarPubMed
12.Pfister, AK, Wul, JT Jr & Saville, PD (2001) Factors determining calcium intake in elderly women of Appalachia. South Med J 94, 10061012.CrossRefGoogle ScholarPubMed
13.Ervin, RB & Kennedy-Stephenson, J (2002) Mineral intakes of elderly adult supplement and non-supplement users in the third National Health and Nutrition Examination Survey. J Nutr 132, 34223427.CrossRefGoogle ScholarPubMed
14.Cussler, EC, Going, SB, Houtkooper, LB, Stanford, VA, Blew, RM, Flint-Wagner, HG, Metcalfe, LL, Choi, JE & Lohman, TG (2005) Exercise frequency and calcium intake predict 4-year bone changes in postmenopausal women. Osteoporos Int 16, 21292141.CrossRefGoogle ScholarPubMed
15.Liberman, UA, Weiss, SR, Broll, J, Minne, HW, Quan, H, Bell, NH, Rodriguez-Portales, J, Downs, RW Jr, Dequeker, J & Favus, M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333, 14371443.CrossRefGoogle Scholar
16.Black, DM, Cummings, SR, Karpf, DB et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348, 15351541.CrossRefGoogle ScholarPubMed
17.Cummings, SR, Black, DM, Thompson, DE et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280, 20772082.CrossRefGoogle ScholarPubMed
18.Chesnut, CH 3rd, Silverman, S, Andriano, K et al. (2002) A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 109, 267276.CrossRefGoogle Scholar
19.Neer, RM, Arnaud, CD, Zanchetta, JR et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344, 14341441.CrossRefGoogle ScholarPubMed
20.Reid, IR, Ames, RW, Evans, MC, Gamble, GD & Sharpe, SJ (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328, 460464.CrossRefGoogle Scholar
21.Winzenberg, TM, Riley, M, Frendin, S, Oldenburg, B & Jones, G (2005) Sociodemographic factors associated with calcium intake in premenopausal women: a cross-sectional study. Eur J Clin Nutr 59, 463466.CrossRefGoogle ScholarPubMed
22.Schlienger, JL, Pradignac, A & Grunenberger, F (1995) Nutrition of the elderly: a challenge between facts and needs. Horm Res 43, 4651.CrossRefGoogle ScholarPubMed
23.Meunier, F (2005) [Nutrition in the elderly person]. Soins Gerontol issue 51, 1618.Google ScholarPubMed
24.Walker, J & Ball, M (1993) Increasing calcium intake in women on a low-fat diet. Eur J Clin Nutr 47, 718723.Google ScholarPubMed
25.Boonen, S, Rizzoli, R, Meunier, PJ, Stone, M, Nuki, G, Syversen, U, Lehtonen-Veromaa, M, Lips, P, Johnell, O & Reginster, JY (2004) The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int 15, 511519.CrossRefGoogle ScholarPubMed
26.Boonen, S, Body, JJ, Boutsen, Y, Devogelaer, JP, Goemaere, S, Kaufman, JM, Rozenberg, S & Reginster, JY (2005) Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 16, 239254.CrossRefGoogle ScholarPubMed
27.Compston, J (2005) Guidelines for the management of osteoporosis: the present and the future. Osteoporos Int 16, 11731176.CrossRefGoogle ScholarPubMed
28.Dhesi, JK, Allain, TJ, Mangoni, AA & Jackson, SH (2006) The implications of a growing evidence base for drug use in elderly patients. Part 4. Vitamin D and bisphosphonates for fractures and osteoporosis. Br J Clin Pharmacol 61, 521528.CrossRefGoogle ScholarPubMed
29.Mowe, M & Bohmer, T (2002) Reduced appetite. A predictor for undernutrition in aged people. J Nutr Health Aging 6, 8183.Google ScholarPubMed
30.Lowenstein, FW (1982) Nutritional status of the elderly in the United States of America, 1971–1974. J Am Coll Nutr 1, 165177.CrossRefGoogle ScholarPubMed
31.Boonen, S, Bischoff-Ferrari, HA, Cooper, C, Lips, P, Ljunggren, O, Meunier, PJ & Reginster, JY (2006) Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 78, 257270.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Baseline characteristics of women according to category of dietary calcium intake: European postmenopausal osteoporotic women

Figure 1

Fig. 1 Proportion of women in the global population, women aged less than 75 years and women more than 75 years of age meeting different thresholds (░, <800 mg/d; □, 800–1300 mg/d; ▒, >1300 mg/d) of dietary calcium intake: European postmenopausal osteoporotic women

Figure 2

Table 2 Dietary calcium intake and the percentage of women taking calcium supplements in different countries: European postmenopausal osteoporotic women

Figure 3

Fig. 2 Proportion of women in different European countries meeting different thresholds (░, <800 mg/d; □, 800–1300 mg/d; ▒, >1300 mg/d) of dietary calcium intake: European postmenopausal osteoporotic women